U.S. Markets open in 58 mins

FDA rejects Malvern pharma firm's non-opioid pain killer for a second time

John George
FDA rejects Malvern pharma firm's non-opioid pain killer for a second time

Recro Pharma said it strongly disagreed when the FDA's assessment and will continue to push to get its drug approved.